Cargando…
Targeted Next-Generation Sequencing of Liquid Biopsy Samples from Patients with NSCLC
Liquid biopsy tests have become an integral part of the molecular diagnosis of patients with non-small cell lung cancer (NSCLC). We describe a new test panel that uses very low input (20 ng) of cell-free nucleic acids extracted from human plasma, which is designed to yield results in less than 72 h....
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912015/ https://www.ncbi.nlm.nih.gov/pubmed/33494470 http://dx.doi.org/10.3390/diagnostics11020155 |